Wikipedia -WSS

Wikipedia

author：focus 2025-09-29 21:26:57 - browse：52158

Five elderly people have been blinded in one eye by a severe side effect after receiving injections of a newly approved treatment for eye disease from Apellis Pharmaceuticals. The frequency of this side effect — a severe type of eye inflammation — is low but its cause remains unknown.

The new safety information related to the Apellis drug, called Syfovre, was presented Saturday by a committee of eye disease experts at the annual meeting of the American Society of Retinal Specialists (ASRS).

Apellis cooperated with the ASRS analysis but the company also announced its own internal review Saturday that found fewer cases of retinal occlusive vasculitis, a type of severe eye inflammation that blocks blood flow to the retina and can result in blindness. The rate of retinal occlusive vasculitis reported remains “very rare,” the company said, adding that there is no evidence linking the drug product or its manufacturing to the severe side effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Medicare Advantage beneficiaries sue Humana over algorithm use

WSS

Personalized medicine goes far beyond genetics

How to keep neuroscience’s past racism from being its future

Medicare drug price negotiation hasn't dried up venture capital

Florida officials tell state schools to teach AP Psychology 'in its entirety'

In Spain, a hospital brews its own CAR

Alnylam reports growth in sales of rare disease treatments

explore

Wikipedia

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

Can sheer will power keep patients alive in their dying hours?

Trump demands the U.S. pay no more for drugs than other countries … again

Three trends to watch in biotech in 2024

Medicare details structure of new drug price negotiation program

Biotech startup Celsius cuts 75% of staff ahead of first trial start

FDA approval of Sarepta Duchenne genetic therapy gives me hope

2 officers injured in shooting in Orlando, police say

Malaria cases in Florida and Texas: Here’s what you need to know

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

leisure time

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

In Spain, a hospital brews its own CAR

Why health records don't always know when patients are dead

CDC recommends RSV monoclonal antibody for infants

CRISPR gene editing developments we’re watching in 2024

Biotech startup Celsius cuts 75% of staff ahead of first trial start

focus

knowledge

hotspot

explore